If you are of childbearing potential, discuss appropriate contraception with your provider and consider discontinuing semaglutide at least 2 months before a planned pregnancy due to its long half-life
Since their mechanisms of action are independent of LDLR pathways, associated therapeutics offer potential treatments for populations lacking functional LDLRs, such as those with homozygous familial hypercholesterolemia (HoFH)
They enhance glucose-dependent insulin secretion, suppress glucagon release, delay gastric emptying, and reduce appetite, thereby contributing to glucose homeostasis and body weight regulation (29, 30)
If your body isnt cooperating, its time for a medical approach that treats the cause , not the symptoms
German physician and scientist Matthias Tschp and American chemist Richard DiMarchi, who had met at Eli Lilly, were working on synthetic versions of glucagon to treat sudden drops in blood glucose when they unexpectedly found long-term dosing caused weight-loss in obese mice
